Blue Trust Inc. Has $678,000 Stake in CVS Health Co. (NYSE:CVS)

Blue Trust Inc. boosted its holdings in shares of CVS Health Co. (NYSE:CVS) by 56.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,099 shares of the pharmacy operator’s stock after acquiring an additional 5,426 shares during the quarter. Blue Trust Inc.’s holdings in CVS Health were worth $678,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. acquired a new stake in shares of CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC lifted its position in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC bought a new stake in CVS Health during the third quarter worth approximately $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CVS. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. Evercore ISI upped their price target on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Piper Sandler decreased their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Finally, Mizuho cut their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $68.12.

CVS Health Stock Down 0.1 %

NYSE CVS opened at $56.84 on Friday. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock’s 50 day moving average is $51.28 and its two-hundred day moving average is $56.17. The company has a market capitalization of $71.53 billion, a price-to-earnings ratio of 14.43, a PEG ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the prior year, the business posted $2.21 earnings per share. The business’s revenue was up 6.3% compared to the same quarter last year. Equities analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.68%. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.